Posted on 12/1/20
CANbridge Pharmaceuticals Closes $43 Million Series E Financing
CANbridge Pharmaceuticals Inc., a company developing and commercializing innovative drugs to treat rare diseases and targeted cancers, announced that it has completed a US$43 million Series . . .
Posted on 12/1/20
Va. COVID-19 Cases, Deaths Continue to Rise
COVID-19 rates continued to climb last week in Virginia, with an increase of 16,797 cases since Nov. 23, according to the Virginia Department of Health’s Nov. . . .
Posted on 12/1/20
Boston Scientific Divests BTG Specialty Pharmaceuticals Business for $800M
Boston Scientific (NYSE:BSX) entered into a definitive agreement to sell the its BTG Specialty Pharmaceuticals business to Stark International Lux and SERB SAS, affiliates of SERB, . . .
Posted on 12/1/20
IPO Update: Kinnate Biopharma Proposes Terms For $170 Million IPO
SummaryKinnate Biopharma aims to raise $170 million in an IPO.The firm is developing kinase inhibitor-based treatment candidates for various cancers.KNTE has produced promising results in preclinical . . .
Posted on 12/1/20
Why Novavax Could Be a Bigger COVID Vaccine Winner Than Pfizer and Moderna
Some Americans could receive COVID-19 vaccinations before the end of 2020. Two coronavirus vaccines are in a prime position to win U.S. emergency use authorization (EUA) . . .
Posted on 12/1/20
Pfizer: A 'New' Growth Foundation In Genomic Medicine
SummaryPfizer has been working on New Pfizer for almost a decade. The spin offs of Consumer Health and Upjohn appear to be the last steps.Continuation of . . .
Posted on 12/1/20
Should You Sell Teladoc Health Stock As Coronavirus Vaccines Succeed?
As the world stands on the verge of getting vaccines for COVID-19, investors interested in the pandemic theme are faced with a dilemma. Do they sell . . .
Posted on 12/1/20
Moderna's Coronavirus Vaccine Candidate 100% Effective at Preventing Severe COVID-19
On Monday morning, Moderna (NASDAQ:MRNA) released a highly encouraging primary efficacy analysis for its coronavirus vaccine candidate, mRNA-1273. The company also promised to submit a request . . .
Posted on 12/1/20
Moderna's Coronavirus Vaccine to Be Reviewed by FDA Advisory Committee on Dec. 17
Moderna (NASDAQ:MRNA) reported complete data for its coronavirus vaccine candidate, mRNA-1273, today. It also submitted its application for emergency use authorization to the Food and Drug . . .
Posted on 12/1/20
Cogent Biosciences Announces $60M Public Offering of Shares of Common Stock
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that it has commenced an underwritten public . . .
Posted on 12/1/20
Intellia Therapeutics Proposes Public Offering of Common Stock
CAMBRIDGE, Mass., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both . . .
Posted on 11/30/20
Orioles to Provide COVID-19 Testing for Elev8 Baltimore
The Orioles, in partnership with Major League Baseball (MLB) and the Baltimore Community Foundation (BCF), announced Nov. 30 a plan to facilitate COVID-19 testing for Elev8 . . .
Posted on 11/30/20
Maryland Confirms First COVID-19 Death of Child Between 0 and 9 Years Old
Maryland confirmed its first coronavirus-related death of a child between 0-9 years old on Monday, state data show.Since Sunday, the state reported 16 deaths due to . . .
Posted on 11/30/20
Novavax Makes Progress, Is The Name A Discount Moderna?
The past few months I couldn't help but notice a sizable gap in the valuation of Moderna (MRNA) and Novavax (NVAX), two players in the race . . .
Posted on 11/30/20
Charlesbank Forms Bridges Consumer Healthcare,Acquires ThermaCare from GSK Consumer Healthcare
Funds affiliated with Charlesbank Capital Partners have announced the formation of Bridges Consumer Healthcare in partnership with industry executives Robert Long and Blair Ramey.
Posted on 11/30/20
Castle Harlan Secures $295 Million Refinancing For Its Portfolio Company, Tensar Corp.
Castle Harlan, a New York private equity firm, today announced that it has secured a $295 million refinancing for its portfolio company, Tensar Corp., headquartered in . . .
Posted on 11/30/20
Signant Health Acquires VirTrial
Signant Health, the leading enabler of evidence generation for modern clinical trials, announced today the acquisition of VirTrial, a leading provider of software solutions for remote . . .
Posted on 11/30/20
MacroGenics Announces Achievement of $25 Million in Milestones
ROCKVILLE, MD, Nov. 30, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the . . .
Posted on 11/30/20
Novavax Slips 6% After COVID-19 Vaccine Update
Novavax (NASDAQ:NVAX) provides an update on its COVID-19 vaccine program. NVX?CoV2373 is a stable, prefusion protein antigen derived from the genetic sequence of the SARS-CoV-2 coronavirus . . .
Posted on 11/30/20
Kinaset Therapeutics Launches with a $40M Series A Financing
Kinaset Therapeutics, Inc., a newly-founded biopharmaceutical company, today announced a $40 million Series A financing with a blue-chip investor syndicate of 5AM Ventures, Atlas Venture, and . . .
Posted on 11/30/20
G1 Therapeutics: Depressed Price Before Catalyst, No Apparent Reason
SummaryGTHX stock is depressed but I don't see any reason.PDUFA of Feb. 15, 2021, is a major catalyst.Label expansion, rest of pipeline, cash runway, collaborations - . . .
Posted on 11/30/20
Kinnate Biopharma Seeks IPO For Kinase Inhibitor Approach
SummaryKinnate Biopharma has filed to raise investment capital in a U.S. IPO.The firm is developing treatments for various cancers using a kinase inhibitor approach.KNTE has produced . . .
Posted on 11/30/20
Where Will Pfizer Be in 5 Years?
Most investors who have been following Pfizer (NYSE:PFE) for awhile can't be overly pleased with how it has fared over the last five years. The big . . .
Posted on 11/30/20
Pfizer's Vaccine Candidate Is Effective -- But It Has Issues
As the excitement over Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) vaccine announcement ebbs, some harsh realities have started to set in. The vaccine candidate -- while a . . .
Posted on 11/30/20
3 Key Advantages Moderna Holds Over Pfizer and AstraZeneca
Pfizer (NYSE:PFE) appears to be likely to be the first drugmaker, along with its partner BioNTech (NASDAQ:BNTX), to win U.S. emergency use authorization (EUA) for a . . .

